Skip to main content
Log in

Determining mucosal barrier injury to the oesophagus using CT scan

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

Oral mucositis is recognised as one of the most debilitating complications of high-dose cytostatic chemotherapy used to prepare for haematopoietic stem cell transplantation (HSCT), but very little is known about oesophageal mucositis, as endoscopy is not routinely performed.

Materials and methods

We incorporate the computed tomography (CT) scan in the diagnostic workup of fever during neutropenia to detect evidence of pulmonary complications. This allowed us to evaluate whether mucosal barrier injury to the oesophagus can be determined. We selected 46 patients without oesophageal cancer or immune suppression (controls), who had a normal oesophagus, and measured the mucosal thickness at the upper part (UP), middle part (MP) and lower part (LP) of the oesophagus. Next, we selected 30 patients having a CT scan done for diagnostic purposes within 14 days after HSCT and measured mucosal thickness at the same levels. We also scored oral mucositis and gut toxicity.

Results

The mucosal thickness of the UP, MP and LP, respectively, for the controls (mean ± SD) was 4.1 mm (±1.1), 4.2 mm (±1.2) and 4.8 mm (±1.3), and the corresponding values for the subjects were 5.9 mm (±2.2), 5.9 mm (±2.0) and 7.7 mm (±3.0). Analysis of variance showed statistically significant differences between subjects and controls at all oesophageal levels. All patients suffered from severe oral mucositis at the time.

Conclusion

Hence, mucosal barrier injury to the oesophagus can be objectively measured using CT scan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Blijlevens NMA, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269–1278

    Article  PubMed  CAS  Google Scholar 

  2. Blijlevens NMA, Donnelly JP, de Pauw BE (2002) Impaired gut function as risk factor for invasive candidiasis in neutropenic patients. Br J Haematol 117(2):259–264 (May)

    Article  PubMed  Google Scholar 

  3. Blijlevens NMA, Donnelly JP, DePauw BE (2005) Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 36(8):703–707 (October)

    Article  PubMed  CAS  Google Scholar 

  4. Blijlevens NMA, van’t Land B, Donnelly JP, M’Rabet L, DePauw BE (2004) Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 12:227–233

    Article  PubMed  CAS  Google Scholar 

  5. Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P, Concetta Petti M, Meloni G, Mandelli F (2001) Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 19:756–761

    PubMed  CAS  Google Scholar 

  6. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539

    Article  PubMed  Google Scholar 

  7. Lal DR, Foroutan HR, Su WT, Wolden SL, Boulad F, La Quaglia MP (2006) The management of treatment-related esophageal complications in children and adolescents with cancer. J Pediatr Surg 41(3):495–499 (March)

    Article  PubMed  Google Scholar 

  8. MASCC/ISOO, T.M.s.g.o. (2005) Summary of evidence-based clinical practice guidelines for care of patients with oral and gastrointestinal mucositis (2005 updat). http://www.mascc.org/ Ref Type: Internet Communication

  9. National Cancer Institute Common Toxicity Criteria (1999) Version 3. http://ctep.cancer.gov/forms/CTCAEv3.pd 2006. Ref Type: Internet Communication

  10. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett A, Barloon J, Sallah S (2005) Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 61(3):772–778 (March 1)

    Article  PubMed  Google Scholar 

  11. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R (2006) Risk factors for acute esophagitis in non-small cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66(1):100–107

    Article  PubMed  Google Scholar 

  12. Yang VX, Tang SJ, Gordon ML, Qi B, Gardiner G, Cirocco M, Kortan P, Haber GB, Kandel G, Vitkin IA, Wilson BC, Marcon NE (2005) Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience. Gastrointest Endosc 61(7):879–890 (June)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. M. A. Blijlevens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blijlevens, N.M.A., Donnelly, J.P., Yakar, D. et al. Determining mucosal barrier injury to the oesophagus using CT scan. Support Care Cancer 15, 1105–1108 (2007). https://doi.org/10.1007/s00520-006-0192-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-006-0192-9

Keywords

Navigation